Monte Rosa Therapeutics Inc.
GLUE | NASDAQ
$12.26
+$0.13 (+1.07%)
At close: Sep 21, 2026, 4:00 PM ET
$12.34
+$0.08 (+0.65%)
Pre-market:
Sep 22, 2026, 5:22 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -34.09 | -7.08 | -2.15 | -3.31 | -12.84 | -25.83 |
PEG Ratio | 0.64 | 0.11 | -0.15 | -0.07 | -0.14 | -0.07 |
PS Ratio | 10.53 | 6.78 | n/a | n/a | n/a | n/a |
PB Ratio | 5.59 | 2.30 | 1.62 | 1.32 | 2.73 | -19.13 |
P/FCF Ratio | -47.37 | 13.50 | -4.62 | -3.41 | -13.75 | -35.25 |
P/OCF Ratio | -57.13 | 12.21 | -6.63 | -3.89 | -16.01 | -40.43 |
OCF/S Ratio | -18.43 | 55.53 | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.17 | 0.19 | 0.26 | 0.17 | n/a | -1.39 |
Quick Ratio | 6.12 | 2.40 | 5.07 | 10.79 | 20.96 | 1.49 |
Current Ratio | 6.12 | 2.40 | 5.07 | 10.79 | 20.96 | 1.49 |
Asset Turnover | 0.28 | 0.17 | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -29.86 | n/a | n/a |
Return on Equity | -16.57% | -32.61% | -75.51% | -39.98% | -21.28% | 73.63% |
Return on Assets | -8.61% | -16.57% | -44.56% | -31.69% | -20.19% | -72.66% |
Return on Invested Capital | -13.56% | -28.41% | -55.05% | -35.13% | -20.84% | -139.33% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 93.24% | 89.26% | n/a | n/a | n/a | n/a |
Net Profit Margin | -31.23% | -96.14% | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -32.12% | -92.74% | n/a | n/a | n/a | n/a |
Operating Profit Margin | -43.83% | -107.26% | n/a | n/a | n/a | n/a |
FCF Margin | -22.23% | 50.26% | n/a | n/a | n/a | n/a |
EBITDA Margin | -25.36% | -82% | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove GLUE